A Study of DXC006 With Immune Checkpoint Inhibitors or Platinum for Small Cell Lung CancerInhibitors or Platinum-Based Agents for Small Cell Lung Cancer.
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Small Cell Lung Cancer
Related studies linked through entity extraction aliases.
18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors
- Status
- RECRUITING
- Phase
- NA
SMARCA4/2 Inhibitor for POU2F3-Positive SCLC
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Comprehensive Oncogenomic Mapping and Exploration in Thoracic and Head & Neck Oncology
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Nab-Paclitaxel Combined With Local Therapy in Relapsed SCLC
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Study of Tarlatamab + ZL-1310 +/- Anti-programmed Death Ligand 1 (Anti-PD-L1) in Small Cell Lung Cancer (SCLC)
- Status
- RECRUITING
- Phase
- PHASE1
68Ga-PFD3 PET Imaging for the Diagnosis and Evaluation of Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
MDT-Based Nursing for Small Cell Lung Cancer During Chemo-Immunotherapy
- Status
- COMPLETED
- Phase
- NA
Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE2
SYS6090 Combination Therapy in Advanced Lung Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Tarlatamab for SCLC Brain Metastases
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Adebrelimab Combined With Oral Etoposide for Elderly Patients and Patients With Poor Performance Status in Small Cell Lung Cancer: An Exploratory Clinical Study
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Prospective, Single-arm, Phase II Clinical Study of Irinotecan Hydrochloride Liposome Injection Combined With Platinum and Immune Checkpoint Inhibitors Combined With Anlotinib for the Maintenance of Extensive Small Cell Lung Cancer After First-line Induction
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Prospective, Single-Arm, Single-Center Phase II Study Evaluating the Efficacy and Safety of Chidamide Combined With PD-L1 Inhibitor, Carboplatin, and Etoposide as First-Line Treatment in Patients With Extensive-Stage Small-Cell Lung Cancer (ES-SCLC)
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
CXCR4 PET/CT for Predicting Outcome in Limited-Stage Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- N/A
Expanded Access to ABBV-706
- Status
- AVAILABLE
- Phase
- N/A
SKB500 Combinations in Patients With Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Phase II Clinical Study to Evaluate HLX43 in Combination With Serplulimab in Subjects With Advanced Lung Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2